Conference Reports for NATAP

AASLD 61th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2010 Back

In vitro studies investigating the mechanism of interaction between TMC435 and hepatic transporters       Reported by Jules Levin AASLD Nov 2 Boston   M. T. Huisman,1 J. Snoeys,1 J. Monbaliu,1 M. Martens,2 V. Sekar,3 A. Raoof4 1Janssen Pharmaceutical Companies of Johnson & Johnson, Research and Development, Beerse, Belgium; 2Formerly Tibotec, Beerse, Belgium; 3Tibotec Inc., Titusville, NJ, USA; 4Tibotec, Beerse, Belgium Disclosure: MTH, JS, and JM are employees of Janssen Pharmaceutical Companies of Johnson & Johnson. VS and AR are employees of Tibotec.